• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冷冻保存对从脐带血CD34(+)细胞体外分化而来的自然杀伤细胞的功能没有影响。

Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cells.

作者信息

Domogala Anna, Madrigal J Alejandro, Saudemont Aurore

机构信息

Anthony Nolan Research Institute, London, United Kingdom; University College London, London, United Kingdom.

Anthony Nolan Research Institute, London, United Kingdom; University College London, London, United Kingdom.

出版信息

Cytotherapy. 2016 Jun;18(6):754-9. doi: 10.1016/j.jcyt.2016.02.008. Epub 2016 Apr 15.

DOI:10.1016/j.jcyt.2016.02.008
PMID:27090754
Abstract

BACKGROUND AIMS

Natural killer (NK) cells offer the potential for a powerful cellular immunotherapy because they can target malignant cells without being direct effectors of graft-versus-host disease. We have previously shown that high numbers of functional NK cells can be differentiated in vitro from umbilical cord blood (CB) CD34(+) cells. To develop a readily available, off-the-shelf cellular product, it is essential that NK cells differentiated in vitro can be frozen and thawed while maintaining the same phenotype and functions.

METHODS

We evaluated the phenotype and function of fresh and frozen NK cells differentiated in vitro. We also assessed whether the concentration of NK cells at the time of freezing had an impact on cell viability.

RESULTS

We found that cell concentration of NK cells at the time of freezing did not have an impact on their viability and on cell recovery post-thaw. Moreover, freezing of differentiated NK cells in vitro did not affect their phenotype, cytotoxicity and degranulation capacity toward K562 cells, cytokine production and proliferation.

CONCLUSIONS

We are therefore able to generate large numbers of functional NK cells from CB CD34(+) cells that maintain the same phenotype and function post-cryopreservation, which will allow for multiple infusions of a highly cytotoxic NK cell product.

摘要

背景与目的

自然杀伤(NK)细胞具有强大的细胞免疫治疗潜力,因为它们能够靶向恶性细胞,而不会引发移植物抗宿主病。我们之前已经证明,大量功能性NK细胞可在体外从脐带血(CB)CD34(+)细胞分化而来。为开发一种随时可用的现成细胞产品,体外分化的NK细胞在冷冻和解冻后仍保持相同的表型和功能至关重要。

方法

我们评估了体外分化的新鲜和冷冻NK细胞的表型和功能。我们还评估了冷冻时NK细胞的浓度是否对细胞活力有影响。

结果

我们发现冷冻时NK细胞的细胞浓度对其活力和解冻后的细胞回收率没有影响。此外,体外分化的NK细胞冷冻不会影响其表型、对K562细胞的细胞毒性和脱颗粒能力、细胞因子产生及增殖。

结论

因此,我们能够从CB CD34(+)细胞中生成大量功能性NK细胞,这些细胞在冷冻保存后保持相同的表型和功能,这将允许多次输注高细胞毒性的NK细胞产品。

相似文献

1
Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cells.冷冻保存对从脐带血CD34(+)细胞体外分化而来的自然杀伤细胞的功能没有影响。
Cytotherapy. 2016 Jun;18(6):754-9. doi: 10.1016/j.jcyt.2016.02.008. Epub 2016 Apr 15.
2
Natural killer cells differentiated in vitro from cord blood CD34 cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cells.与外周血和脐带血自然杀伤细胞相比,体外从脐带血CD34细胞分化而来的自然杀伤细胞作为免疫疗法使用更具优势。
Cytotherapy. 2017 Jun;19(6):710-720. doi: 10.1016/j.jcyt.2017.03.068. Epub 2017 Apr 17.
3
High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.从脐带血 CD34+ 细胞中高效对数扩增功能性人自然杀伤细胞用于过继性癌症免疫治疗。
PLoS One. 2010 Feb 15;5(2):e9221. doi: 10.1371/journal.pone.0009221.
4
A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.一种从极少量经选择性获取的冷冻保存脐带血中扩增大量CD56(+)自然杀伤细胞用于移植后免疫治疗的新方法。
Cytotherapy. 2015 Nov;17(11):1582-93. doi: 10.1016/j.jcyt.2015.07.020.
5
Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells.与动员的造血干细胞或新鲜分离的脐血造血干细胞相比,冷冻脐血造血干细胞在体外可分化为数量更多的功能性自然杀伤细胞。
PLoS One. 2014 Jan 29;9(1):e87086. doi: 10.1371/journal.pone.0087086. eCollection 2014.
6
Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.脐带间充质干细胞可增加脐血自然杀伤细胞的扩增。
Biol Blood Marrow Transplant. 2008 Sep;14(9):1031-1038. doi: 10.1016/j.bbmt.2008.06.016.
7
Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.环孢素A对白细胞介素-15激活的脐带血自然杀伤细胞功能的影响。
Cytotherapy. 2008;10(4):397-405. doi: 10.1080/14653240802129885.
8
Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.源自体外扩增和激活的脐血单个核细胞的自然杀伤细胞和自然杀伤样T细胞的特性:对过继性细胞免疫治疗的意义
Exp Hematol. 2009 Oct;37(10):1216-29. doi: 10.1016/j.exphem.2009.07.009. Epub 2009 Jul 26.
9
Challenges of cancer therapy with natural killer cells.自然杀伤细胞用于癌症治疗的挑战。
Cytotherapy. 2015 Mar;17(3):245-9. doi: 10.1016/j.jcyt.2014.09.007. Epub 2014 Dec 18.
10
Strong capacity of differentiated PD-L1 CAR-modified UCB-CD34 cells and PD-L1 CAR-modified UCB-CD34-derived NK cells in killing target cells and restoration of the anti-tumor function of PD-1-high exhausted T Cells.具有强大分化能力的 PD-L1 CAR 修饰的 UCB-CD34 细胞和 PD-L1 CAR 修饰的 UCB-CD34 衍生 NK 细胞,能够杀伤靶细胞,并恢复 PD-1 高表达耗竭 T 细胞的抗肿瘤功能。
Stem Cell Res Ther. 2024 Aug 13;15(1):257. doi: 10.1186/s13287-024-03871-5.

引用本文的文献

1
Prospects and limitations of NK cell adoptive therapy in clinical applications.自然杀伤细胞过继性治疗在临床应用中的前景与局限性
Cancer Metastasis Rev. 2025 Jun 25;44(3):57. doi: 10.1007/s10555-025-10273-3.
2
Good manufacturing practice production of an off-the-shelf CD34 progenitor-derived NK cell product with preserved anti-tumor functionality post-infusion in NOD/SCID/IL2Rg mice.在NOD/SCID/IL2Rg小鼠中,采用良好生产规范生产一种现成的CD34祖细胞衍生的NK细胞产品,该产品在输注后保留抗肿瘤功能。
Cell Mol Life Sci. 2025 May 26;82(1):210. doi: 10.1007/s00018-025-05727-4.
3
Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation.
预处理用白细胞介素-15 和白细胞介素-18 可挽救自然杀伤细胞在冻存后由颗粒酶 B 介导的细胞凋亡。
Nat Commun. 2024 May 10;15(1):3937. doi: 10.1038/s41467-024-47574-0.
4
Optimizing the cryopreservation and post-thaw recovery of natural killer cells is critical for the success of off-the-shelf platforms.优化自然杀伤细胞的冷冻保存和复苏后恢复对于现成平台的成功至关重要。
Front Immunol. 2023 Dec 15;14:1304689. doi: 10.3389/fimmu.2023.1304689. eCollection 2023.
5
Chimeric antigen receptor engineered natural killer cells for cancer therapy.用于癌症治疗的嵌合抗原受体工程化自然杀伤细胞。
Exp Hematol Oncol. 2023 Aug 10;12(1):70. doi: 10.1186/s40164-023-00431-0.
6
Physicochemical Mechanisms of Protection Offered by Agarose Encapsulation during Cryopreservation of Mammalian Cells in the Absence of Membrane-Penetrating Cryoprotectants.琼脂糖包埋在无膜渗透保护剂的情况下对哺乳动物细胞冷冻保存提供保护的理化机制。
ACS Appl Bio Mater. 2023 Jun 19;6(6):2226-2236. doi: 10.1021/acsabm.3c00098. Epub 2023 May 22.
7
Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment.CARs 疗法的现代进展与未来治疗新方法的探索
Int J Mol Sci. 2022 Nov 30;23(23):15006. doi: 10.3390/ijms232315006.
8
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential.嵌合抗原受体工程化自然杀伤细胞:具有巨大潜力的癌症免疫治疗新武器。
Exp Hematol Oncol. 2022 Nov 2;11(1):85. doi: 10.1186/s40164-022-00341-7.
9
[Clinical observation of CD19-TANK cells in the treatment of relapsed/refractory B-cell lymphoma].CD19-TANK细胞治疗复发/难治性B细胞淋巴瘤的临床观察
Zhonghua Xue Ye Xue Za Zhi. 2022 Feb 14;43(2):153-156. doi: 10.3760/cma.j.issn.0253-2727.2022.02.012.
10
Engineered NK Cells Against Cancer and Their Potential Applications Beyond.工程化自然杀伤细胞治疗癌症及其在癌症治疗之外的潜在应用
Front Immunol. 2022 Feb 15;13:825979. doi: 10.3389/fimmu.2022.825979. eCollection 2022.